Although there are no specific studies on glioblastoma (GBM), it is known that high levels of sPD-L1 in the blood are associated with poor prognosis in non-small cell lung cancer and diffuse large B-cell lymphoma [24,25]. This evidence concerns the gene SPDL1 and diffuse large B-cell lymphoma.